These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
269 related items for PubMed ID: 18799057
1. Effects of anti-CD20 monoclonal antibody as a rescue treatment for ANCA-associated idiopathic systemic vasculitis with or without overt renal involvement. Roccatello D, Baldovino S, Alpa M, Rossi D, Napoli F, Naretto C, Cavallo R, Giachino O. Clin Exp Rheumatol; 2008; 26(3 Suppl 49):S67-71. PubMed ID: 18799057 [Abstract] [Full Text] [Related]
5. Rituximab as Induction Therapy in Eosinophilic Granulomatosis with Polyangiitis Refractory to Conventional Immunosuppressive Treatment: A 36-Month Follow-Up Analysis. Thiel J, Troilo A, Salzer U, Schleyer T, Halmschlag K, Rizzi M, Frede N, Venhoff A, Voll RE, Venhoff N. J Allergy Clin Immunol Pract; 2017 Jun; 5(6):1556-1563. PubMed ID: 28916432 [Abstract] [Full Text] [Related]
8. Treatment of refractory retrobulbar granuloma with rituximab in a patient with ANCA-negative Wegener's granulomatosis: a case report. Ooka S, Maeda A, Ito H, Omata M, Yamada H, Ozaki S. Mod Rheumatol; 2009 Jun; 19(1):80-3. PubMed ID: 18806927 [Abstract] [Full Text] [Related]
10. Rituximab for remission induction in elderly patients with ANCA-associated vasculitis. Timlin H, Lee SM, Manno RL, Seo P, Geetha D. Semin Arthritis Rheum; 2015 Aug; 45(1):67-9. PubMed ID: 25796088 [Abstract] [Full Text] [Related]
11. Rituximab in relapsing or refractory ANCA-associated vasculitis: a case series of 16 patients. Wendt M, Gunnarsson I, Bratt J, Bruchfeld A. Scand J Rheumatol; 2012 Mar; 41(2):116-9. PubMed ID: 22118245 [Abstract] [Full Text] [Related]
12. Rituximab versus cyclophosphamide for ANCA-associated vasculitis with renal involvement. Geetha D, Specks U, Stone JH, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Fessler BJ, Ding L, Tchao NK, Ikle D, Jepson B, Brunetta P, Fervenza FC, Rituximab for ANCA-Associated Vasculitis Immune Tolerance Network Research Group. J Am Soc Nephrol; 2015 Apr; 26(4):976-85. PubMed ID: 25381429 [Abstract] [Full Text] [Related]
15. Treatment of severe renal disease in ANCA positive and negative small vessel vasculitis with rituximab. Shah S, Hruskova Z, Segelmark M, Morgan MD, Hogan J, Lee SK, Dale J, Harper L, Tesar V, Jayne DR, Geetha D. Am J Nephrol; 2015 Apr; 41(4-5):296-301. PubMed ID: 26044574 [Abstract] [Full Text] [Related]
16. Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss). Mohammad AJ, Hot A, Arndt F, Moosig F, Guerry MJ, Amudala N, Smith R, Sivasothy P, Guillevin L, Merkel PA, Jayne DR. Ann Rheum Dis; 2016 Feb; 75(2):396-401. PubMed ID: 25467294 [Abstract] [Full Text] [Related]